← 產業報告目錄

Diagnostic Imaging Market by Modality (MRI (Very High (7T+), High (3T+), Low (<3T)), Ultrasound (3D/4D, Doppler, Contrast), CT, X-Ray (Digital, Portable), Mammography, SPECT, PET)), Application (OB/Gyn, CVD, Onco, Neuro) & End User-Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-09-15頁數 394報告編號 MD2367

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global diagnostic imaging market is projected to reach USD 32.90 billion by 2030 from USD 26.51 billion in 2025, at a CAGR of 4.4% from 2025 to 2030. The market is growing due to the increased use of non-invasive technology. The expansion of the diagnostic imaging market is also linked to heightened government initiatives, clinical trials, and a strong emphasis on research and development. “The ultrasound systems segment held the largest share of the market in 2024.” Based on modality, the diagnostic imaging market is segmented into CT scanners, MRI systems, ultrasound systems, X-ray imaging systems, nuclear imaging systems, and mammography systems. The ultrasound systems segment held the largest market share in 2024. Advancements in 3D and 4D imaging, along with AI features and improved portability, are enhancing the use of ultrasound in point-of-care and emergency settings, making it even more accessible. The rising prevalence of chronic diseases and the increasing demand for early and accurate diagnoses are solidifying the dominance of ultrasound systems in the market. “The radiology/general imaging applications segment held the largest share of the ultrasound systems market during the forecast period.” The ultrasound systems market is segmented by applications: radiology/general imaging, cardiology, obstetrics/gynecology, vascular applications, urology, and other applications. From 2025 to 2030, the radiology/general imaging application segment held the largest share of the market. Demand in this market is driven by the increasing use of point-of-care ultrasonography (POCUS) among internal medicine, emergency departments, and general practitioners. “The market in the Asia Pacific region is expected to witness the highest growth during the forecast period.” The diagnostic imaging market in the APAC region is projected to register the highest CAGR during the forecast period. This growth is primarily driven by the evolving healthcare infrastructure and the increasing focus of major players in the region. Hospitals and diagnostic facilities are making significant investments in modern imaging equipment, particularly in rapidly developing countries like China and India. These factors are expected to contribute to the expansion of the diagnostic imaging market in this area. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1 (48%), Tier 2 (36%), and Tier 3 (16%) • By Designation: D-level Executives (14%), C-level Executives (10%), and Others (76%) • By Region: North America (40%), Europe (32%), Asia Pacific (20%), Latin America (5%), and the Middle East & Africa (3%) The prominent players in the diagnostic imaging market are Siemens Healthineers (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), and FUJIFILM Corporation (Japan), among others. Research Coverage This report studies the diagnostic imaging market based on modality, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their growth trends and forecasts the revenue of the industry for five leading geographies, along with corresponding countries Reasons to Buy the Report The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall diagnostic imaging market and its subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities. This report provides insights on the following pointers: • Analysis of key drivers (growing geriatric population and subsequent rise in chronic diseases, increasing demand for early diagnosis across clinical applications, technological advancements in diagnostic imaging modalities, and increasing funding and investments by public-private organizations), restraints (high cost of diagnostic imaging systems, technological limitations associated with standalone systems, unfavorable reimbursement scenario, and inadequate supply of helium), opportunities (emerging economies offer high growth potential, increasing establishment of hospitals and diagnostic imaging centers, adoption of AI and analytics in diagnostic imaging, growing adoption of teleradiology, and contract-based radiology solutions and mobile solutions), and challenges (hospital budget cuts, increasing adoption of refurbished diagnostic imaging systems, and shortage of trained professionals) influencing the growth of the diagnostic imaging market • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the diagnostic imaging market • Market Development: Comprehensive information about lucrative markets. The report analyzes the diagnostic imaging market across varied regions • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the diagnostic imaging market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like GE HealthCare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), and FUJIFILM Corporation (Japan).
目錄 Table of Contents
1 INTRODUCTION 32 1.1 STUDY OBJECTIVES 32 1.2 MARKET DEFINITION 32 1.3 STUDY SCOPE 33 1.3.1 MARKETS CONSIDERED AND REGIONS COVERED 33 1.3.2 INCLUSIONS AND EXCLUSIONS 34 1.4 YEARS CONSIDERED 34 1.5 CURRENCY CONSIDERED 35 1.6 STAKEHOLDERS 35 1.7 SUMMARY OF CHANGES 35 2 RESEARCH METHODOLOGY 37 2.1 RESEARCH DATA 37 2.1.1 SECONDARY RESEARCH 38 2.1.2 PRIMARY RESEARCH 39 2.1.2.1 Primary sources 39 2.1.2.2 Key industry insights 40 2.1.2.3 Breakdown of primaries 40 2.2 MARKET SIZE ESTIMATION 41 2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION 43 2.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION 44 2.2.3 GROWTH FORECAST 45 2.2.4 CAGR PROJECTIONS 45 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION APPROACH 46 2.4 MARKET SHARE ESTIMATION 47 2.5 RESEARCH ASSUMPTIONS 47 2.6 RISK ASSESSMENT 48 2.7 GROWTH RATE ASSUMPTIONS 48 3 EXECUTIVE SUMMARY 49 4 PREMIUM INSIGHTS 52 4.1 DIAGNOSTIC IMAGING MARKET OVERVIEW 52 4.2 NORTH AMERICA: DIAGNOSTIC IMAGING MARKET, BY REGION AND END USER, 2025 53 4.3 REGIONAL SNAPSHOT OF DIAGNOSTIC IMAGING MARKET 54   5 MARKET OVERVIEW 55 5.1 INTRODUCTION 55 5.2 MARKET DYNAMICS 55 5.2.1 DRIVERS 56 5.2.1.1 Growing geriatric population and the rising prevalence of associated diseases 56 5.2.1.2 Increasing demand for early diagnosis and widening scope of clinical applications 57 5.2.1.3 Technological advancements in diagnostic imaging modalities 57 5.2.1.4 Increasing investments, funds, and grants by public-private organizations 58 5.2.2 RESTRAINTS 59 5.2.2.1 High cost of diagnostic imaging systems 59 5.2.2.2 Technological limitations associated with standalone systems 60 5.2.2.3 Unfavorable reimbursement scenario 60 5.2.2.4 Shortage of helium 61 5.2.3 OPPORTUNITIES 61 5.2.3.1 Emerging economies offer high growth potential 61 5.2.3.2 Adoption of AI and analytics in diagnostic imaging 61 5.2.3.3 Increasing establishment of hospitals and diagnostic imaging centers 62 5.2.3.4 Increasing adoption of teleradiology 63 5.2.3.5 Contract-based radiology solutions and mobile solutions 64 5.2.4 CHALLENGES 64 5.2.4.1 Hospital budget cuts 64 5.2.4.2 Increasing adoption of refurbished diagnostic imaging systems 64 5.2.4.3 Dearth of trained professionals 65 5.3 PRICING ANALYSIS 65 5.4 VALUE CHAIN ANALYSIS 67 5.4.1 RESEARCH & DEVELOPMENT 67 5.4.2 MANUFACTURING & ASSEMBLY 67 5.4.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALE SERVICES 67 5.5 ECOSYSTEM ANALYSIS 68 5.6 SUPPLY CHAIN ANALYSIS 68 5.6.1 PROMINENT COMPANIES 68 5.6.2 SMALL & MEDIUM-SIZED ENTERPRISES 68 5.6.3 END USERS 68 5.7 PORTER’S FIVE FORCES ANALYSIS 69 5.7.1 BARGAINING POWER OF BUYERS 69 5.7.2 BARGAINING POWER OF SUPPLIERS 70 5.7.3 THREAT OF NEW ENTRANTS 70 5.7.4 THREAT OF SUBSTITUTES 70 5.7.5 INTENSITY OF COMPETITIVE RIVALRY 70 5.8 REGULATORY LANDSCAPE 70 5.8.1 NORTH AMERICA 70 5.8.1.1 US 70 5.8.1.2 Canada 71 5.8.2 EUROPE 72 5.8.3 ASIA PACIFIC 73 5.8.3.1 Japan 73 5.8.3.2 China 73 5.8.3.3 India 75 5.9 TRENDS IMPACTING CUSTOMER BUSINESS 75 5.9.1 INCREASING ADOPTION OF HYBRID DIAGNOSTIC IMAGING MODALITIES 75 5.10 TECHNOLOGY ANALYSIS 76 5.10.1 KEY TECHNOLOGIES 76 5.10.1.1 Magnetic resonance imaging (MRI) 76 5.10.1.2 Computed tomography (CT) 77 5.10.1.3 Ultrasound imaging 77 5.10.2 COMPLEMENTARY TECHNOLOGIES 77 5.10.2.1 Picture archiving and communication systems (PACS) 77 5.10.2.2 Artificial intelligence (AI) for image analysis 78 5.10.2.3 Radiology information systems (RIS) 78 5.10.3 ADJACENT TECHNOLOGIES 78 5.10.3.1 Digital pathology 78 5.10.3.2 Molecular imaging/PET-CT 79 5.10.3.3 Wearable imaging sensors 79 5.11 REIMBURSEMENT SCENARIO 79 5.12 TRADE ANALYSIS 86 5.12.1 IMPORT DATA FOR COMPUTED TOMOGRAPHY SYSTEMS, BY COUNTRY, 2020─2024 (USD THOUSAND) 87 5.12.2 EXPORT DATA FOR COMPUTED TOMOGRAPHY SYSTEMS, BY COUNTRY, 2020─2024 (USD THOUSAND) 88 5.12.3 TRADE ANALYSIS FOR ULTRASOUND SYSTEMS 89 5.12.3.1 Import data for ultrasound systems, by country, 2020─2024 (USD Thousand) 89 5.12.3.2 Export data for ultrasound systems, by country, 2020─2024 (USD Thousand) 90 5.12.4 TRADE ANALYSIS FOR MAGNETIC RESONANCE IMAGING SYSTEMS 91 5.12.4.1 Import data for magnetic resonance imaging systems, by country, 2020─2024 (USD Thousand) 91 5.12.4.2 Export data for magnetic resonance imaging systems, by country, 2020─2024 (USD Thousand) 92 5.12.5 TRADE ANALYSIS FOR X-RAY SYSTEMS 93 5.12.5.1 Import data for X-ray systems, by country, 2020─2024 (USD Thousand) 93 5.12.5.2 Export data for X-ray systems, by country, 2020─2024 (USD Thousand) 94 5.13 PATENT ANALYSIS 95 5.14 CASE STUDY ANALYSIS 101 5.15 KEY CONFERENCES AND EVENTS (2025–2026) 102 5.16 UNMET NEEDS 103 5.17 IMPACT OF AI ON DIAGNOSTIC IMAGING MARKET 103 5.17.1 INTRODUCTION 103 5.17.2 MARKET POTENTIAL OF AI IN DIAGNOSTIC IMAGING 103 5.17.3 AI USE CASES 104 5.17.4 KEY COMPANIES IMPLEMENTING AI 104 5.17.5 FUTURE OF GENERATIVE AI IN DIAGNOSTIC IMAGING 104 5.18 IMPACT OF 2025 US TARIFF 104 5.18.1 INTRODUCTION 104 5.18.2 KEY TARIFF RATES 105 5.18.3 PRICE IMPACT ANALYSIS 105 5.18.4 IMPACT ON COUNTRY/REGION 105 5.18.4.1 United States 105 5.18.4.2 Europe 106 5.18.4.3 Asia Pacific 106 5.18.5 IMPACT ON END-USE INDUSTRIES 106 6 DIAGNOSTIC IMAGING MARKET, BY APPLICATION 107 6.1 INTRODUCTION 108 6.2 X-RAY IMAGING SYSTEMS 108 6.2.1 GENERAL RADIOGRAPHY 108 6.2.1.1 Wide-scale application in chest imaging to drive market 108 6.2.2 DENTISTRY 109 6.2.2.1 High prevalence of dental disorders to drive market 109 6.2.3 FLUOROSCOPY 109 6.2.3.1 Rising use in gastrointestinal imaging to support market growth 109 6.3 MRI SYSTEMS 110 6.3.1 BRAIN & NEUROLOGICAL MRI 111 6.3.1.1 Rising incidence of neurodegenerative diseases to drive market 111 6.3.2 SPINE & MUSCULOSKELETAL MRI 112 6.3.2.1 Ability to diagnose musculoskeletal disorders to drive market 112 6.3.3 VASCULAR MRI 112 6.3.3.1 Adoption of AI to support market growth 112 6.3.4 PELVIC & ABDOMINAL MRI 113 6.3.4.1 Ability to detect prostate and cervical cancer to propel market 113 6.3.5 BREAST MRI 113 6.3.5.1 Growing awareness about early breast cancer screening to drive market 113 6.3.6 CARDIAC MRI 114 6.3.6.1 Rising incidence of CVD to support market growth 114 6.4 ULTRASOUND SYSTEMS 114 6.4.1 RADIOLOGY/GENERAL IMAGING 115 6.4.1.1 Extensive use in image-guided radiotherapy and radiology ultrasound to drive market 115 6.4.2 OBSTETRICS/GYNECOLOGY 116 6.4.2.1 Advancements in AI models for image guidance to support market growth 116 6.4.3 CARDIOLOGY 117 6.4.3.1 Rising prevalence of cardiovascular diseases to drive market 117 6.4.4 VASCULAR 117 6.4.4.1 Identification of vessel blockages and blot clots for early disease diagnosis to support market growth 117 6.4.5 UROLOGY 118 6.4.5.1 Growing awareness about therapeutic benefits of urological ultrasound to propel market 118 6.4.6 OTHER APPLICATIONS 118 6.5 CT SCANNERS 119 6.5.1 CARDIOLOGY 120 6.5.1.1 Rising incidence of obesity and hypertension to propel market 120 6.5.2 ONCOLOGY 120 6.5.2.1 Rising burden of cancer to drive market 120 6.5.3 NEUROLOGY 121 6.5.3.1 Increasing incidence of dementia and Alzheimer’s to fuel market 121 6.5.4 OTHER APPLICATIONS 122 6.6 NUCLEAR IMAGING SYSTEMS 122 6.6.1 ONCOLOGY 123 6.6.1.1 Ability to distinguish between benign and malignant tumors to drive market 123 6.6.2 CARDIOLOGY 123 6.6.2.1 Rising incidence of coronary heart disease to support market 123 6.6.3 NEUROLOGY 124 6.6.3.1 Rising use of SPECT and PET systems for brain perfusion imaging to drive market 124 6.6.4 OTHER APPLICATIONS 125 6.7 MAMMOGRAPHY SYSTEMS 125 6.7.1 TECHNOLOGICAL ADVANCEMENTS IN MAMMOGRAPHY SYSTEMS TO SUPPORT MARKET GROWTH 125   7 DIAGNOSTIC IMAGING MARKET, BY MODALITY 127 7.1 INTRODUCTION 128 7.2 CT SCANNERS 128 7.2.1 CONVENTIONAL CT SCANNERS 129 7.2.1.1 High-slice CT scanners 130 7.2.1.1.1 High image resolution to drive market 130 7.2.1.2 Mid-slice CT scanners 131 7.2.1.2.1 Increasing affordability to propel market 131 7.2.1.3 Low-slice CT scanners 132 7.2.1.3.1 Low costs and rising adoption in emerging economies to drive market 132 7.2.2 CONE-BEAM CT SCANNERS 133 7.2.2.1 Growing applications in dental & ENT scanning to drive market 133 7.3 ULTRASOUND SYSTEMS 134 7.3.1 ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY 134 7.3.2 2D ULTRASOUND SYSTEMS 135 7.3.2.1 Rise in demand for minimal invasive surgeries leading to increased use of 2D ultrasound 135 7.3.3 3D AND 4D ULTRASOUND 136 7.3.3.1 IMPROVED DIAGNOSIS WITH 3D ULTRASOUND TECHNOLOGY 136 7.3.4 DOPPLER ULTRASOUND 137 7.3.4.1 Growing application in cardiology and vascular to drive market growth 137 7.3.4.2 Contrast-enhanced ultrasound systems 138 7.3.4.2.1 Innovative product launches offering real-time monitoring capabilities to fuel market 138 7.3.5 ULTRASOUND SYSTEMS MARKET, BY PORTABILITY 139 7.3.5.1 Trolley/Cart-based ultrasound systems 140 7.3.5.1.1 Utilization in pediatric and abdominal applications to propel market 140 7.3.5.2 Compact/Handheld ultrasound systems 141 7.3.5.2.1 High portability and user-friendly features to drive market 141 7.4 X-RAY IMAGING SYSTEMS 142 7.4.1 X-RAY IMAGING SYSTEMS MARKET, BY TYPE 142 7.4.1.1 Digital X-ray imaging systems 143 7.4.1.2 Analog X-ray imaging systems 144 7.4.1.2.1 High risk of radiation exposure and limitations to impede market growth 144 7.4.2 X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY 145 7.4.2.1 Stationary X-ray imaging systems 146 7.4.2.1.1 Efficient configuration integration in diagnostic clinics to propel market 146 7.4.2.2 Portable X-ray imaging systems 146 7.4.2.2.1 Rising use in trauma care and emergency departments to boost adoption 146 7.5 MRI SYSTEMS 147 7.5.1 MRI SYSTEMS MARKET, BY ARCHITECTURE 148 7.5.1.1 Closed MRI systems 148 7.5.1.1.1 Reduced examination time and improved image quality to drive market 148 7.5.1.2 Open MRI systems 149 7.5.1.2.1 High patient comfort to boost adoption 149 7.5.2 MRI SYSTEMS MARKET, BY FIELD STRENGTH 150 7.5.2.1 High and very-high-field MRI systems 151 7.5.2.1.1 High safety & image resolution to drive market 151 7.5.2.2 Low-to-mid-field MRI systems 151 7.5.2.2.1 Technological limitations to restrain market 151 7.5.2.3 Ultra-high-field MRI systems 152 7.5.2.3.1 High utilization in musculoskeletal & neurological applications to support market growth 152 7.6 NUCLEAR IMAGING SYSTEMS 153 7.6.1 SPECT SYSTEMS 154 7.6.2 PET SYSTEMS 154 7.6.3 HYBRID SPECT SYSTEMS 155 7.6.3.1 Enhanced resolution to support market growth 155 7.7 MAMMOGRAPHY SYSTEMS 156 7.7.1 RISING AWARENESS ABOUT BREAST CANCER TO SUPPORT MARKET GROWTH 156 8 DIAGNOSTIC IMAGING MARKET, BY END USER 158 8.1 INTRODUCTION 159 8.2 HOSPITALS 159 8.2.1 INCREASED NUMBER OF MRI, PET, CT SCANS TO PROPEL DIAGNOSTIC IMAGING MARKET 159 8.3 DIAGNOSTIC IMAGING CENTERS 160 8.3.1 RISING ESTABLISHMENT OF PRIVATE IMAGING CENTERS TO FUEL MARKET 160 8.4 OTHER END USERS 161 9 DIAGNOSTIC IMAGING MARKET, BY REGION 163 9.1 INTRODUCTION 164 9.2 NORTH AMERICA 165 9.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 165 9.2.2 US 171 9.2.2.1 High incidence of chronic diseases to drive market 171 9.2.3 CANADA 175 9.2.3.1 Rising cases of chronic disease to support market growth 175   9.3 ASIA PACIFIC 179 9.3.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 180 9.3.2 JAPAN 186 9.3.2.1 Presence of universal healthcare coverage to fuel market 186 9.3.3 CHINA 190 9.3.3.1 Government initiatives for establishment of hospitals to drive market 190 9.3.4 INDIA 194 9.3.4.1 Improvements in healthcare infrastructure and rising incidence of CVD to drive market 194 9.3.5 SOUTH KOREA 199 9.3.5.1 Growing access to advanced ultrasound systems to support market growth 199 9.3.6 AUSTRALIA 202 9.3.6.1 Increasing healthcare spending to propel market 202 9.3.7 REST OF ASIA PACIFIC 207 9.4 EUROPE 211 9.4.1 EUROPE: MACROECONOMIC OUTLOOK 211 9.4.2 GERMANY 216 9.4.2.1 High number of MRI units to drive the market 216 9.4.3 UK 220 9.4.3.1 Increasing investments in diagnostic imaging to drive market 220 9.4.4 ITALY 224 9.4.4.1 Established healthcare infrastructure to support market growth 224 9.4.5 SPAIN 228 9.4.5.1 Growing access to advanced cancer diagnostics to propel market 228 9.4.6 REST OF EUROPE 232 9.5 LATIN AMERICA 236 9.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK 236 9.5.2 BRAZIL 241 9.5.2.1 High export of medical devices to propel market 241 9.5.3 MEXICO 245 9.5.3.1 Rising R&D initiatives on oncology imaging to support market growth 245 9.5.4 REST OF LATIN AMERICA 249 9.6 MIDDLE EAST & AFRICA 252 9.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 253 9.6.2 GCC COUNTRIES 258 9.6.2.1 Integration of AI to support market growth 258 9.6.3 REST OF MIDDLE EAST & AFRICA 262 9.6.3.1 Advancements in healthcare sector to support market growth 262   10 COMPETITIVE LANDSCAPE 266 10.1 INTRODUCTION 266 10.2 KEY PLAYERS’ STRATEGIES/RIGHT TO WIN 266 10.3 REVENUE ANALYSIS, 2022–2024 269 10.4 MARKET SHARE ANALYSIS 270 10.5 RANKING OF KEY PLAYERS, 2024 272 10.6 COMPANY VALUATION AND FINANCIAL METRICS 272 10.7 BRAND/PRODUCT COMPARISON 274 10.8 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 275 10.8.1 STARS 275 10.8.2 PERVASIVE PLAYERS 275 10.8.3 EMERGING LEADERS 275 10.8.4 PARTICIPANTS 275 10.8.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 277 10.8.5.1 Company footprint 277 10.8.5.2 Modality footprint 278 10.8.5.3 Application footprint 279 10.8.5.4 End user footprint 280 10.8.5.5 Region footprint 281 10.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 282 10.9.1 PROGRESSIVE COMPANIES 282 10.9.2 RESPONSIVE COMPANIES 282 10.9.3 DYNAMIC COMPANIES 282 10.9.4 STARTING BLOCKS 282 10.9.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2024 284 10.9.5.1 Detailed list of key startups/SMEs 284 10.9.5.2 Competitive benchmarking of key startups/SMEs 285 10.10 COMPETITIVE SCENARIO 286 10.10.1 PRODUCT LAUNCHES AND APPROVALS 286 10.10.2 DEALS 287 10.10.3 EXPANSIONS 289 11 COMPANY PROFILES 290 11.1 KEY PLAYERS 290 11.1.1 SIEMENS HEALTHINEERS 290 11.1.1.1 Business overview 290 11.1.1.2 Products offered 292 11.1.1.3 Recent developments 294 11.1.1.3.1 Product launches, upgrades, and approvals 294 11.1.1.3.2 Deals 296 11.1.1.3.3 Expansions 298   11.1.1.4 MnM view 298 11.1.1.4.1 Key strengths 298 11.1.1.4.2 Strategic choices 298 11.1.1.4.3 Weaknesses & competitive threats 298 11.1.2 GE HEALTHCARE 299 11.1.2.1 Business overview 299 11.1.2.2 Products offered 300 11.1.2.3 Recent developments 305 11.1.2.3.1 Product launches, upgrades, and approvals 305 11.1.2.3.2 Deals 306 11.1.2.3.3 Expansions 308 11.1.2.3.4 Other developments 309 11.1.2.4 MnM view 309 11.1.2.4.1 Key strengths 309 11.1.2.4.2 Strategic choices 309 11.1.2.4.3 Weaknesses and competitive threats 309 11.1.3 KONINKLIJKE PHILIPS N.V. 310 11.1.3.1 Business overview 310 11.1.3.2 Products offered 312 11.1.3.3 Recent developments 314 11.1.3.3.1 Product launches, upgrades, and approvals 314 11.1.3.3.2 Deals 314 11.1.3.3.3 Expansions 315 11.1.3.4 MnM view 316 11.1.3.4.1 Key strengths 316 11.1.3.4.2 Strategic choices 316 11.1.3.4.3 Weaknesses and competitive threats 316 11.1.4 FUJIFILM CORPORATION 317 11.1.4.1 Business overview 317 11.1.4.2 Products offered 319 11.1.4.3 Recent developments 321 11.1.4.3.1 Product launches, upgrades, and approvals 321 11.1.4.3.2 Deals 322 11.1.4.3.3 Expansions 323 11.1.4.4 MnM view 323 11.1.4.4.1 Right to win 323 11.1.4.4.2 Strategic choices 323 11.1.4.4.3 Weaknesses & competitive threats. 324 11.1.5 CANON 325 11.1.5.1 Business overview 325 11.1.5.2 Products offered 327 11.1.5.3 Recent developments 330 11.1.5.3.1 Product launches, upgrades, and approvals 330 11.1.5.3.2 Deals 331 11.1.5.3.3 Expansions 332 11.1.6 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 333 11.1.6.1 Business overview 333 11.1.6.2 Products offered 334 11.1.6.3 Recent developments 336 11.1.6.3.1 Product launches, upgrades, and approvals 336 11.1.6.3.2 Deals 337 11.1.7 ESAOTE S.P.A 338 11.1.7.1 Business overview 338 11.1.7.2 Products offered 338 11.1.7.3 Recent developments 340 11.1.7.3.1 Product launches, upgrades, and approvals 340 11.1.7.3.2 Deals 340 11.1.8 SAMSUNG HEALTHCARE 341 11.1.8.1 Business overview 341 11.1.8.2 Products offered 342 11.1.8.3 Recent developments 345 11.1.8.3.1 Product launches, upgrades, and approvals 345 11.1.8.3.2 Deals 346 11.1.8.3.3 Other developments 346 11.1.9 SHIMADZU CORPORATION 347 11.1.9.1 Business overview 347 11.1.9.2 Products offered 348 11.1.9.3 Recent developments 350 11.1.9.3.1 Product launches, upgrades, and approvals 350 11.1.9.3.2 Deals 350 11.1.10 CARESTREAM HEALTH 351 11.1.10.1 Business overview 351 11.1.10.2 Products offered 351 11.1.10.3 Recent developments 352 11.1.10.3.1 Product launches, upgrades, and approvals 352 11.1.10.3.2 Deals 353 11.1.11 PLANMED OY 354 11.1.11.1 Business overview 354 11.1.11.2 Products offered 355 11.1.12 HOLOGIC, INC. 356 11.1.12.1 Business overview 356 11.1.12.2 Products offered 357 11.1.12.3 Recent developments 358 11.1.12.3.1 Deals 358 11.1.13 AGFA-GEVAERT GROUP 359 11.1.13.1 Business overview 359 11.1.13.2 Products offered 360 11.1.14 CURVEBEAM AI, LTD. 362 11.1.14.1 Business overview 362 11.1.14.2 Products offered 362 11.1.14.3 Recent developments 363 11.1.14.3.1 Deals 363 11.1.15 UNITED IMAGING HEALTHCARE CO., LTD. 364 11.1.15.1 Business overview 364 11.1.15.2 Products offered 365 11.1.15.3 Recent developments 366 11.1.15.3.1 Product launches, upgrades, and approvals 366 11.1.15.3.2 Deals 367 11.1.15.3.3 Expansions 367 11.2 OTHER PLAYERS 368 11.2.1 ALLENGERS MEDICAL SYSTEMS LTD. 368 11.2.2 ANALOGIC CORPORATION 369 11.2.3 ASPECT IMAGING LTD. 370 11.2.4 BEIJING WANDONG MEDICAL TECHNOLOGY CO., LTD. 371 11.2.5 CHISON MEDICAL TECHNOLOGIES CO., LTD. 372 11.2.6 KONICA MINOLTA, INC. 374 11.2.7 MEDGYN PRODUCTS, INC. 375 11.2.8 NEUSOFT MEDICAL SYSTEMS CO., LTD. 376 11.2.9 PROMED TECHNOLOGY CO., LTD. 378 11.2.10 CMR NAVISCAN 379 11.2.11 CLARIUS 380 11.2.12 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD. 381 11.2.13 SHENZHEN ANKE HIGH-TECH., LTD. 382 11.2.14 STERNMED GMBH 383 11.2.15 TIME MEDICAL SYSTEMS 384 12 APPENDIX 385 12.1 DISCUSSION GUIDE 385 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 390 12.3 CUSTOMIZATION OPTIONS 392 12.4 RELATED REPORTS 392 12.5 AUTHOR DETAILS 393
圖表清單 List of Tables & Figures
TABLE 1 AGE-RELATED DISEASES AND ASSOCIATED DIAGNOSTIC MODALITIES 56 TABLE 2 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING SYSTEMS 58 TABLE 3 REGIONAL PRICING ANALYSIS OF KEY DIAGNOSTIC IMAGING MODALITIES, 2024 (USD) 65 TABLE 4 DIAGNOSTIC IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 69 TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION 71 TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 71 TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 72 TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 73 TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES 73 TABLE 10 MEDICAL REIMBURSEMENT CODES FOR MRI PROCEDURES IN THE US (AS OF 2025) 80 TABLE 11 MEDICAL REIMBURSEMENT CODES FOR CT IMAGING PROCEDURES IN THE US (AS OF 2025) 82 TABLE 12 MEDICAL REIMBURSEMENT CODES FOR PET/CT IMAGING PROCEDURES IN THE US (AS OF 2025) 83 TABLE 13 MEDICAL REIMBURSEMENT CODES FOR ULTRASOUND IMAGING PROCEDURES IN THE US (AS OF 2025) 83 TABLE 14 MEDICAL REIMBURSEMENT CODES FOR MAMMOGRAPHY IMAGING PROCEDURES IN THE US (AS OF 2025) 84 TABLE 15 MEDICAL REIMBURSEMENT CODES FOR RADIOLOGY PROCEDURES IN THE US (AS OF 2025) 84 TABLE 16 CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE 101 TABLE 17 CASE STUDY 2: BETTER VISUALIZATION OF BREAST IMAGES IN WOMEN WITH DENSE BREAST TISSUE 101 TABLE 18 DIAGNOSTIC IMAGING MARKET: LIST OF MAJOR CONFERENCES AND EVENTS 102 TABLE 19 DIAGNOSTIC IMAGING MARKET: UNMET NEEDS 103 TABLE 20 US ADJUSTED RECIPROCAL TARIFF RATES (AS OF APRIL 13, 2025) 105 TABLE 21 DIAGNOSTIC IMAGING MARKET FOR X-RAY SYSTEMS, BY APPLICATION, 2023–2030 (USD MILLION) 108 TABLE 22 DIAGNOSTIC IMAGING MARKET FOR MRI SYSTEMS, BY APPLICATION, 2023–2030 (USD MILLION) 111 TABLE 23 DIAGNOSTIC IMAGING MARKET FOR ULTRASOUND SYSTEMS, BY APPLICATION, 2023–2030 (USD MILLION) 115 TABLE 24 DIAGNOSTIC IMAGING MARKET FOR CT SCANNERS, BY APPLICATION, 2023–2030 (USD MILLION) 119 TABLE 25 DIAGNOSTIC IMAGING MARKET FOR NUCLEAR IMAGING SYSTEMS, BY APPLICATION, 2023–2030 (USD MILLION) 122 TABLE 26 DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 128 TABLE 27 CT SCANNERS MARKET, BY REGION, 2023–2030 (USD MILLION) 129 TABLE 28 CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 129 TABLE 29 CONVENTIONAL CT SCANNERS MARKET, BY REGION, 2023–2030 (USD MILLION) 130 TABLE 30 CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 130 TABLE 31 HIGH-SLICE CT SCANNERS MARKET, BY REGION, 2023–2030 (USD MILLION) 131 TABLE 32 MID-SLICE CT SCANNERS MARKET, BY REGION, 2023–2030 (USD MILLION) 132 TABLE 33 LOW-SLICE CT SCANNERS MARKET, BY REGION, 2023–2030 (USD MILLION) 133 TABLE 34 CBCT SCANNERS MARKET, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 35 ULTRASOUND SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 36 ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 135 TABLE 37 2D ULTRASOUND SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 136 TABLE 38 3D AND 4D ULTRASOUND SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 137 TABLE 39 DOPPLER ULTRASOUND SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 138 TABLE 40 CONTRAST-ENHANCED ULTRASOUND SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 139 TABLE 41 ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 139 TABLE 42 TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 140 TABLE 43 COMPACT/PORTABLE ULTRASOUND SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 141 TABLE 44 X-RAY IMAGING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 142 TABLE 45 X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 142 TABLE 46 DIGITAL X-RAY IMAGING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 144 TABLE 47 ANALOG X-RAY IMAGING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 145 TABLE 48 X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 145 TABLE 49 STATIONARY X-RAY IMAGING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 146 TABLE 50 PORTABLE X-RAY IMAGING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 147 TABLE 51 MRI SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 147 TABLE 52 MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 148 TABLE 53 CLOSED MRI SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 149 TABLE 54 OPEN MRI SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 150 TABLE 55 MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 150 TABLE 56 HIGH AND VERY-HIGH-FIELD MRI SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 151 TABLE 57 LOW-TO-MID-FIELD MRI SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 152 TABLE 58 ULTRA-HIGH-FIELD MRI SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 153 TABLE 59 NUCLEAR IMAGING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 153 TABLE 60 NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 154 TABLE 61 SPECT SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 154 TABLE 62 PET SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 155 TABLE 63 HYBRID SPECT SYSTEM MARKET, BY REGION, 2023–2030 (USD MILLION) 156 TABLE 64 MAMMOGRAPHY SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 157 TABLE 65 DIAGNOSTIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 159 TABLE 66 DIAGNOSTIC IMAGING MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION) 160 TABLE 67 DIAGNOSTIC IMAGING MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2023–2030 (USD MILLION) 161 TABLE 68 DIAGNOSTIC IMAGING MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 162 TABLE 69 DIAGNOSTIC IMAGING MARKET, BY REGION, 2023–2030 (USD MILLION) 164 TABLE 70 NUMBER OF IMAGING TESTS IN UK 164 TABLE 71 NUMBER OF MRI UNITS PER COUNTRY 165 TABLE 72 NORTH AMERICA: MACROECONOMIC OUTLOOK 166 TABLE 73 NORTH AMERICA: DIAGNOSTIC IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 74 NORTH AMERICA: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 167 TABLE 75 NORTH AMERICA: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 167 TABLE 76 NORTH AMERICA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 168 TABLE 77 NORTH AMERICA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 168 TABLE 78 NORTH AMERICA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 168 TABLE 79 NORTH AMERICA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 80 NORTH AMERICA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 169 TABLE 81 NORTH AMERICA: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 169 TABLE 82 NORTH AMERICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 170 TABLE 83 NORTH AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 84 NORTH AMERICA: DIAGNOSTIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 170 TABLE 85 US: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 172 TABLE 86 US: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 87 US: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 88 US: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 173 TABLE 89 US: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 173 TABLE 90 US: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 91 US: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 174 TABLE 92 US: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 174 TABLE 93 US: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 174 TABLE 94 US: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 95 CANADA: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 176 TABLE 96 CANADA: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 97 CANADA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 98 CANADA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 177 TABLE 99 CANADA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 177 TABLE 100 CANADA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 101 CANADA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 178 TABLE 102 CANADA: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 178 TABLE 103 CANADA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 179 TABLE 104 CANADA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 179 TABLE 105 ASIA PACIFIC: MACROECONOMIC INDICATORS 180 TABLE 106 ASIA PACIFIC: DIAGNOSTIC IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 107 ASIA PACIFIC: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 182 TABLE 108 ASIA PACIFIC: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 109 ASIA PACIFIC: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 110 ASIA PACIFIC: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 183 TABLE 111 ASIA PACIFIC: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 184 TABLE 112 ASIA PACIFIC: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 113 ASIA PACIFIC: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 184 TABLE 114 ASIA PACIFIC: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 185 TABLE 115 ASIA PACIFIC: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 185 TABLE 116 ASIA PACIFIC: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 117 ASIA PACIFIC: DIAGNOSTIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 186 TABLE 118 JAPAN: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 187 TABLE 119 JAPAN: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 120 JAPAN: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 121 JAPAN: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 188 TABLE 122 JAPAN: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 123 JAPAN: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 188 TABLE 124 JAPAN: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 189 TABLE 125 JAPAN: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 189 TABLE 126 JAPAN: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 127 CHINA: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 191 TABLE 128 CHINA: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 129 CHINA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 130 CHINA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 192 TABLE 131 CHINA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 192 TABLE 132 CHINA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 133 CHINA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 193 TABLE 134 CHINA: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 193 TABLE 135 CHINA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 194 TABLE 136 CHINA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 137 INDIA: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 195 TABLE 138 INDIA: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 139 INDIA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 140 INDIA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 196 TABLE 141 INDIA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 197 TABLE 142 INDIA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 143 INDIA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 197 TABLE 144 INDIA: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 198 TABLE 145 INDIA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 198 TABLE 146 INDIA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 147 SOUTH KOREA: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 199 TABLE 148 SOUTH KOREA: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 149 SOUTH KOREA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 150 SOUTH KOREA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 200 TABLE 151 SOUTH KOREA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 201 TABLE 152 SOUTH KOREA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 153 SOUTH KOREA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 201 TABLE 154 SOUTH KOREA: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 202 TABLE 155 SOUTH KOREA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 202 TABLE 156 AUSTRALIA: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 203 TABLE 157 AUSTRALIA: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 158 AUSTRALIA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 159 AUSTRALIA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 204 TABLE 160 AUSTRALIA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 205 TABLE 161 AUSTRALIA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 162 AUSTRALIA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 205 TABLE 163 AUSTRALIA: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 206 TABLE 164 AUSTRALIA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 206 TABLE 165 AUSTRALIA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 166 REST OF ASIA PACIFIC: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 207 TABLE 167 REST OF ASIA PACIFIC: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 168 REST OF ASIA PACIFIC: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 169 REST OF ASIA PACIFIC: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 208 TABLE 170 REST OF ASIA PACIFIC: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 209 TABLE 171 REST OF ASIA PACIFIC: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 209 TABLE 172 REST OF ASIA PACIFIC: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 209 TABLE 173 REST OF ASIA PACIFIC: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 210 TABLE 174 REST OF ASIA PACIFIC: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 210 TABLE 175 REST OF ASIA PACIFIC: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 176 EUROPE: MACROECONOMIC OUTLOOK 212 TABLE 177 EUROPE: DIAGNOSTIC IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 178 EUROPE: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 179 EUROPE: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 180 EUROPE: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 213 TABLE 181 EUROPE: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 213 TABLE 182 EUROPE: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 183 EUROPE: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 214 TABLE 184 EUROPE: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 214 TABLE 185 EUROPE: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 215 TABLE 186 EUROPE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 187 EUROPE: DIAGNOSTIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 215 TABLE 188 GERMANY: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 216 TABLE 189 GERMANY: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 190 GERMANY: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 191 GERMANY: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 217 TABLE 192 GERMANY: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 218 TABLE 193 GERMANY: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 194 GERMANY: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 218 TABLE 195 GERMANY: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 219 TABLE 196 GERMANY: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 219 TABLE 197 GERMANY: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 198 UK: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 221 TABLE 199 UK: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 200 UK: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 201 UK: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 222 TABLE 202 UK: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 222 TABLE 203 UK: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 204 UK: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 223 TABLE 205 UK: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 223 TABLE 206 UK: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 223 TABLE 207 UK: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 224 TABLE 208 ITALY: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 225 TABLE 209 ITALY: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 210 ITALY: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 211 ITALY: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 226 TABLE 212 ITALY: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 226 TABLE 213 ITALY: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 214 ITALY: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 227 TABLE 215 ITALY: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 227 TABLE 216 ITALY: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 227 TABLE 217 ITALY: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 218 SPAIN: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 229 TABLE 219 SPAIN: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 220 SPAIN: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 221 SPAIN: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 230 TABLE 222 SPAIN: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 230 TABLE 223 SPAIN: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 230 TABLE 224 SPAIN: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 231 TABLE 225 SPAIN: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 231 TABLE 226 SPAIN: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 231 TABLE 227 SPAIN: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 228 REST OF EUROPE: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 232 TABLE 229 REST OF EUROPE: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 230 REST OF EUROPE: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 231 REST OF EUROPE: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 233 TABLE 232 REST OF EUROPE: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 234 TABLE 233 REST OF EUROPE: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 234 TABLE 234 REST OF EUROPE: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 234 TABLE 235 REST OF EUROPE: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 235 TABLE 236 REST OF EUROPE: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 235 TABLE 237 REST OF EUROPE: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 238 LATIN AMERICA: MACROECONOMIC OUTLOOK 237 TABLE 239 LATIN AMERICA: DIAGNOSTIC IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 237 TABLE 240 LATIN AMERICA: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 241 LATIN AMERICA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 242 LATIN AMERICA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 238 TABLE 243 LATIN AMERICA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 238 TABLE 244 LATIN AMERICA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 245 LATIN AMERICA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 239 TABLE 246 LATIN AMERICA: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 239 TABLE 247 LATIN AMERICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 240 TABLE 248 LATIN AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 249 LATIN AMERICA: DIAGNOSTIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 240 TABLE 250 BRAZIL: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 241 TABLE 251 BRAZIL: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 252 BRAZIL: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 253 BRAZIL: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 242 TABLE 254 BRAZIL: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 243 TABLE 255 BRAZIL: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 256 BRAZIL: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 243 TABLE 257 BRAZIL: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 244 TABLE 258 BRAZIL: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 244 TABLE 259 BRAZIL: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 260 MEXICO: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 245 TABLE 261 MEXICO: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 262 MEXICO: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 263 MEXICO: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 246 TABLE 264 MEXICO: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 247 TABLE 265 MEXICO: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 266 MEXICO: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 247 TABLE 267 MEXICO: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 248 TABLE 268 MEXICO: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 248 TABLE 269 MEXICO: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 270 REST OF LATIN AMERICA: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 249 TABLE 271 REST OF LATIN AMERICA: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 272 REST OF LATIN AMERICA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 273 REST OF LATIN AMERICA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 250 TABLE 274 REST OF LATIN AMERICA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 250 TABLE 275 REST OF LATIN AMERICA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 251 TABLE 276 REST OF LATIN AMERICA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 251 TABLE 277 REST OF LATIN AMERICA: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 251 TABLE 278 REST OF LATIN AMERICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 252 TABLE 279 REST OF LATIN AMERICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 280 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 253 TABLE 281 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 254 TABLE 282 MIDDLE EAST & AFRICA: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 283 MIDDLE EAST & AFRICA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 284 MIDDLE EAST & AFRICA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 255 TABLE 285 MIDDLE EAST & AFRICA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 255 TABLE 286 MIDDLE EAST & AFRICA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 287 MIDDLE EAST & AFRICA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 256 TABLE 288 MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 256 TABLE 289 MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 257 TABLE 290 MIDDLE EAST & AFRICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 291 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 257 TABLE 292 GCC COUNTRIES: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 258 TABLE 293 GCC COUNTRIES: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 294 GCC COUNTRIES: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 295 GCC COUNTRIES: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 259 TABLE 296 GCC COUNTRIES: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 260 TABLE 297 GCC COUNTRIES: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 298 GCC COUNTRIES: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 260 TABLE 299 GCC COUNTRIES: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 261 TABLE 300 GCC COUNTRIES: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 261 TABLE 301 GCC COUNTRIES: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 302 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2023–2030 (USD MILLION) 262 TABLE 303 REST OF MIDDLE EAST & AFRICA: CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 304 REST OF MIDDLE EAST & AFRICA: CONVENTIONAL CT SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 305 REST OF MIDDLE EAST & AFRICA: ULTRASOUND SYSTEMS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 263 TABLE 306 REST OF MIDDLE EAST & AFRICA: ULTRASOUND SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 264 TABLE 307 REST OF MIDDLE EAST & AFRICA: X-RAY IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 308 REST OF MIDDLE EAST & AFRICA: X-RAY IMAGING SYSTEMS MARKET, BY PORTABILITY, 2023–2030 (USD MILLION) 264 TABLE 309 REST OF MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2023–2030 (USD MILLION) 265 TABLE 310 REST OF MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2023–2030 (USD MILLION) 265 TABLE 311 REST OF MIDDLE EAST & AFRICA: NUCLEAR IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 312 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIAGNOSTIC IMAGING MARKET, 2022–2025 266 TABLE 313 DIAGNOSTIC IMAGING MARKET: DEGREE OF COMPETITION 270 TABLE 314 DIAGNOSTIC IMAGING MARKET: MODALITY FOOTPRINT 278 TABLE 315 DIAGNOSTIC IMAGING MARKET: APPLICATION FOOTPRINT 279 TABLE 316 DIAGNOSTIC IMAGING MARKET: END USER FOOTPRINT 280 TABLE 317 DIAGNOSTIC IMAGING MARKET: REGION FOOTPRINT 281 TABLE 318 DIAGNOSTIC IMAGING MARKET: KEY STARTUPS/SMES 284 TABLE 319 DIAGNOSTIC IMAGING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 285 TABLE 320 DIAGNOSTIC IMAGING MARKET: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–JUNE 2025 287 TABLE 321 DIAGNOSTIC IMAGING MARKET: DEALS, JANUARY 2022–JUNE 2025 288 TABLE 322 DIAGNOSTIC IMAGING MARKET: EXPANSIONS, JANUARY 2022–JUNE 2025 289 TABLE 323 SIEMENS HEALTHINEERS: COMPANY OVERVIEW 290 TABLE 324 SIEMENS HEALTHINEERS: PRODUCTS OFFERED 292 TABLE 325 SIEMENS HEALTHINEERS: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–JUNE 2025 294 TABLE 326 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022–JUNE 2025 296 TABLE 327 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2022–JUNE 2025 298 TABLE 328 GE HEALTHCARE: COMPANY OVERVIEW 299 TABLE 329 GE HEALTHCARE: PRODUCTS OFFERED 300 TABLE 330 GE HEALTHCARE: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–JUNE 2025 305 TABLE 331 GE HEALTHCARE: DEALS, JANUARY 2022–JUNE 2025 306 TABLE 332 GE HEALTHCARE: EXPANSIONS, JANUARY 2022–JUNE 2025 308 TABLE 333 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 309 TABLE 334 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 310 TABLE 335 KONIKLIJKE PHILIPS: PRODUCTS OFFERED 312 TABLE 336 KONINKLIJKE PHILIPS N.V. PRODUCT LAUNCHES, UPGRADES, AND APPROVALS JANUARY 2022–JUNE 2025 314 TABLE 337 PHILIPS HEALTHCARE: DEALS, JANUARY 2022–JUNE 2025 314 TABLE 338 PHILIPS HEALTHCARE.: EXPANSIONS, JANUARY 2022–JUNE 2025 315 TABLE 339 FUJIFILM CORPORATION: COMPANY OVERVIEW 317 TABLE 340 FUJIFLIM CORPORATION: PRODUCTS OFFERED 319 TABLE 341 FUJIFLIM CORPORATION: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–JUNE 2025 321 TABLE 342 FUJIFLIM CORPORATION: DEALS, JANUARY 2022–JUNE 2025 322 TABLE 343 FUJIFLIM CORPORATION: EXPANSIONS, JANUARY 2022–JUNE 2025 323 TABLE 344 CANON : COMPANY OVERVIEW 325 TABLE 345 CANON: PRODUCTS OFFERED 327 TABLE 346 CANON MEDICAL SYSTEM: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–JUNE 2025 330 TABLE 347 CANON MEDICAL SYSTEM: DEALS, JANUARY 2022–JUNE 2025 331 TABLE 348 CANON MEDICAL SYSTEM: EXPANSIONS, JANUARY 2022–JUNE 2025 332 TABLE 349 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 333 TABLE 350 SHEZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: PRODUCTS OFFERED 334 TABLE 351 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–JUNE 2025 336 TABLE 352 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: DEALS, JANUARY 2022–JUNE 2025 337 TABLE 353 ESAOTE SPA: BUSINESS OVERVIEW 338 TABLE 354 ESAOTE SPA: PRODUCTS OFFERED 338 TABLE 355 ESAOTE SPA: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–JUNE 2025 340 TABLE 356 ESAOTE SPA: DEALS, JANUARY 2022–JUNE 2025 340 TABLE 357 SAMSUNG HEALTHCARE: COMPANY OVERVIEW 341 TABLE 358 SAMSUNG HEALTHCARE: PRODUCTS OFFERED 342 TABLE 359 SAMSUNG HEALTHCARE: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–JUNE 2025 345 TABLE 360 SAMSUNG HEALTHCARE: DEALS, JANUARY 2022–JUNE 2025 346 TABLE 361 SAMSUNG HEALTHCARE.: OTHER DEVELOPMENTS, JANUARY 2022–JUNE 2025 346 TABLE 362 SHIMADZU CORPORATION: BUSINESS OVERVIEW 347 TABLE 363 SHIMADZU CORPORATION: PRODUCTS OFFERED 348 TABLE 364 SHIMADZU CORPORATION: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–JUNE 2025 350 TABLE 365 SHIMADZU CORPORATION: DEALS, JANUARY 2022–JUNE 2025 350 TABLE 366 CARESTREAM HEALTH: BUSINESS OVERVIEW 351 TABLE 367 CARESTREAM HEALTH: PRODUCTS OFFERED 351 TABLE 368 CARESTREAM HEALTH: PRODUCT APPROVALS, UPGRADES, AND LAUNCHES, JANUARY 2022–JUNE 2025 352 TABLE 369 CARESTREAM HEALTH: DEALS, JANUARY 2022–JUNE 2025 353 TABLE 370 PLANMED OY: BUSINESS OVERVIEW 354 TABLE 371 PLANMED OY: PRODUCTS OFFERED 355 TABLE 372 HOLOGIC, INC.: COMPANY OVERVIEW 356 TABLE 373 HOLOGIC, INC.: PRODUCTS OFFERED 357 TABLE 374 HOLOGIC, INC.: DEALS, JANUARY 2022–JUNE 2025 358 TABLE 375 AGFA-GEVAERT GROUP: BUSINESS OVERVIEW 359 TABLE 376 AGFA-GEVAERTA GROUP: PRODUCTS OFFERED 360 TABLE 377 CURVEBEAM AI, LTD.: BUSINESS OVERVIEW 362 TABLE 378 CURVEBEAM AI: PRODUCTS OFFERED 362 TABLE 379 CURVEBEAM AI: DEALS, JANUARY 2022–JUNE 2025 363 TABLE 380 UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY OVERVIEW 364 TABLE 381 UNITED IMAGING HEALTHCARE CO., LTD.: PRODUCTS OFFERED 365 TABLE 382 UNITED IMAGING HEALTHCARE CO., LTD.: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–JUNE 2025 366 TABLE 383 UNITED IMAGING HEALTHCARE CO., LTD.: DEALS, JANUARY 2022–JUNE 2025 367 TABLE 384 UNITED IMAGING HEALTHCARE CO., LTD.: EXPANSIONS, JANUARY 2022–JUNE 2025 367 TABLE 385 ALLENGERS MEDICAL SYSTEMS LTD: COMPANY OVERVIEW 368 TABLE 386 ANALOGIC CORPORATION: COMPANY OVERVIEW 369 TABLE 387 ASPECT IMAGING LTD: COMPANY OVERVIEW 370 TABLE 388 BEIJING WANDONG MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 371 TABLE 389 CHISON MEDICAL TECHNOLOGIES CO.,LTD.: COMPANY OVERVIEW 372 TABLE 390 KONICA MINOLTA, INC.: COMPANY OVERVIEW 374 TABLE 391 MEDGYN PRODUCTS, INC.: COMPANY OVERVIEW 375 TABLE 392 NEUSOFT MEDICAL SYSTEMS CO., LTD: COMPANY OVERVIEW 376 TABLE 393 PROMED TECHNOLOGY CO., LTD: COMPANY OVERVIEW 378 TABLE 394 CMR NAVISCAN: COMPANY OVERVIEW 379 TABLE 395 CLARIUS: COMPANY OVERVIEW 380 TABLE 396 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD: COMPANY OVERVIEW 381 TABLE 397 SHENZHEN ANKE HIGH-TECH., LTD: COMPANY OVERVIEW 382 TABLE 398 STERNMED GMBH: COMPANY OVERVIEW 383 TABLE 399 TIME MEDICAL SYSTEMS: COMPANY OVERVIEW 384 FIGURE 1 RESEARCH DESIGN 37 FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 40 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 41 FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 42 FIGURE 5 MARKET SIZE ESTIMATION FOR DIAGNOSTIC IMAGING MARKET: APPROACH 1 (COMPANY REVENUE ESTIMATION) 43 FIGURE 6 DIAGNOSTIC IMAGING MARKET: BOTTOM-UP APPROACH FOR MARKET SIZE ESTIMATION 44 FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 45 FIGURE 8 DATA TRIANGULATION METHODOLOGY 46 FIGURE 9 DIAGNOSTIC IMAGING MARKET, BY MODALITY, 2025 VS. 2030 (USD MILLION) 49 FIGURE 10 DIAGNOSTIC IMAGING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 50 FIGURE 11 DIAGNOSTIC IMAGING MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 50 FIGURE 12 GROWING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET 52 FIGURE 13 HOSPITALS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2025 53 FIGURE 14 JAPAN TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 54 FIGURE 15 DIAGNOSTIC IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55 FIGURE 16 VALUE CHAIN ANALYSIS 67 FIGURE 17 SUPPLY CHAIN ANALYSIS 69 FIGURE 18 DIAGNOSTICS IMAGING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 76 FIGURE 19 DIAGNOSTICS IMAGING MARKET: IMPORT SCENARIO FOR COMPUTED TOMOGRAPHY SYSTEMS (HS CODE 902212) 87 FIGURE 20 DIAGNOSTICS IMAGING MARKET: EXPORT SCENARIO FOR COMPUTED TOMOGRAPHY SYSTEMS (HS CODE 902212) 88 FIGURE 21 DIAGNOSTICS IMAGING MARKET: IMPORT SCENARIO FOR ULTRASOUND SYSTEMS (HS CODE 901812) 89 FIGURE 22 DIAGNOSTICS IMAGING MARKET: EXPORT SCENARIO FOR ULTRASOUND SYSTEMS (HS CODE 901812) 90 FIGURE 23 DIAGNOSTICS IMAGING MARKET: IMPORT SCENARIO FOR MAGNETIC RESONANCE IMAGING SYSTEMS (HS CODE 901813) 91 FIGURE 24 DIAGNOSTICS IMAGING MARKET: EXPORT SCENARIO FOR MAGNETIC RESONANCE IMAGING SYSTEMS (HS CODE 901813) 92 FIGURE 25 DIAGNOSTICS IMAGING MARKET: IMPORT SCENARIO FOR X-RAY SYSTEMS (HS CODE 902214) 93 FIGURE 26 DIAGNOSTICS IMAGING MARKET: EXPORT SCENARIO FOR X-RAY SYSTEMS (HS CODE 902214) 94 FIGURE 27 TOP 10 PATENT APPLICANTS FOR CT SCANNERS (JANUARY 2015–AUGUST 2025) 95 FIGURE 28 TOP 10 PATENT APPLICANTS FOR MRI SYSTEMS (JANUARY 2015–AUGUST 2025) 96 FIGURE 29 TOP 10 PATENT APPLICANTS FOR ULTRASOUND IMAGING SYSTEMS (JANUARY 2015–DECEMBER 2025) 97 FIGURE 30 TOP 10 PATENT APPLICANTS FOR MAMMOGRAPHY SYSTEMS (JANUARY 2015–DECEMBER 2025) 98 FIGURE 31 TOP 10 PATENT APPLICANTS FOR X-RAY IMAGING SYSTEMS (JANUARY 2015–DECEMBER 2025) 99 FIGURE 32 TOP 10 PATENT APPLICANTS FOR NUCLEAR IMAGING SYSTEMS (JANUARY 2015–DECEMBER 2025) 100 FIGURE 33 COMPUTED RADIOGRAPHY VS. DIRECT RADIOGRAPHY 143 FIGURE 34 NORTH AMERICA: DIAGNOSTIC IMAGING MARKET SNAPSHOT 166 FIGURE 35 ASIA PACIFIC: DIAGNOSTIC IMAGING MARKET SNAPSHOT 181 FIGURE 36 REVENUE ANALYSIS OF TOP FIVE PLAYERS, 2022–2024 (USD MILLION) 269 FIGURE 37 MARKET SHARE OF KEY PLAYERS, 2024 270 FIGURE 38 RANKING OF KEY PLAYERS, 2024 272 FIGURE 39 EV/EBITDA OF TOP THREE PLAYERS, 2025 272 FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF TOP THREE VENDORS, 2025 273 FIGURE 41 BRAND/PRODUCT COMPARISON 274 FIGURE 42 DIAGNOSTIC IMAGING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 276 FIGURE 43 DIAGNOSTIC IMAGING MARKET: COMPANY FOOTPRINT 277 FIGURE 44 DIAGNOSTIC IMAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 283 FIGURE 45 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2024) 291 FIGURE 46 GE HEALTHCARE: COMPANY SNAPSHOT (2024) 300 FIGURE 47 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024) 311 FIGURE 48 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2024) 318 FIGURE 49 CANON INC.: COMPANY SNAPSHOT (2024) 326 FIGURE 50 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2022) 333 FIGURE 51 SAMSUNG HEALTHCARE: COMPANY SNAPSHOT (2024) 342 FIGURE 52 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2024) 348 FIGURE 53 HOLOGIC, INC.: COMPANY SNAPSHOT (2024) 357 FIGURE 54 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT (2024) 360 FIGURE 55 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY SNAPSHOT (2024) 364

同分類最新報告(醫療器材)

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們